Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 812 results for "pfizer drugmaker pfizer"

These Two New Areas Were Behind Pfizer's Impressive Second Quarter Profits

Pfizer acquires Bamboo Therapeutics

Deal brings gene therapy technology and key manufacturing capabilities Department: Business Keywords: rare disease, pharmaceuticals, gene therapy, Duchenne, DMD Further bolstering its rare disease unit, Pfizer has paid $150 million to acquire ... Chemical & Engineering News, 3 weeks ago

121 images for pfizer drugmaker pfizer

Healthcare Finance News, 5 days ago
Business Insider India, 5 days ago
Yahoo! Finance, 5 days ago
Xconomy, 5 days ago
Business Insider India, 5 days ago
Business Recorder, 5 days ago
Investor's Business Daily, 3 weeks ago
FiercePharma, 2 weeks ago
Motley Fool, 2 months ago
SRN News, 1 month ago

Pfizer, Germany's Merck begin large ovarian cancer trial

Pfizer Inc and German drugmaker Merck KGaA on Wednesday said they had begun a late-stage trial of their immuno-oncology drug avelumab in combination with standard treatment for ovarian cancer. The 950-patient study will enroll patients with advanced ovarian ...
 Reuters1 month ago Lilly breast cancer drug stumbles, but trial continues  Yahoo! Finance2 weeks ago Lilly breast cancer drug stumbles; trial continues  Pharma Live2 weeks ago Eli Lilly to Continue Breakthrough Breast Cancer Drug Trial Despite Failed Test  Fortune2 weeks ago

Pfizer Inc. Paves Way for Pfenex Inc by Returning Lucentis Biosimilar Rights

Pfizer Inc. ( NYSE:PFE ), working on the research and development (R&D) of different versions of the biosimilars has decided to give the complete rights of Pfenex's PF582, a biosimilar to Lucentis (ranibizumab injection) to the parent company.
 Bidness Etc2 weeks ago Pfizer Acquires Gene Therapy Specialist Bamboo Therapeutics  PredictWallStreet3 weeks ago Pfizer Inc. Stock Climbs on Bamboo Therapeutics Acquisition Deal  Bidness Etc3 weeks ago Pfizer Surges to 12-Year Highs, Acquires Gene Therapy Company  Before It's News3 weeks ago
Financial Buzz

Pfizer beats estimates as new cancer, arthritis drugs grow

New York: Pfizer Inc posted second-quarter earnings that beat analysts estimates, thanks to strong sales of its newest drugs for cancer and rheumatoid arthritis. Profit excluding some items was 64 cents a share, according to a statement on Tuesday ...
 Oman Observer3 weeks ago Pfizer Beats Estimates Even as Biggest Product Falls Short  Bloomberg3 weeks ago Pfizer Beats Estimates On Strong New Product Sales  Financial Buzz3 weeks ago Pfizer beats once again after strong sales of new products  BullBearings3 weeks ago
Irish Times

Pfizer earnings beat estimates on sales of generics

Largest US drugmaker gives no hint on whether it will split but expects decision by year end about 3 hours ago Updated: 11 minutes ago Photograph: Bloomberg Pfizer reported better-than-expected quarterly results, driven by lower taxes and ...
 Irish Times3 weeks ago 3 More Drugmakers Beat Q2 Earnings Estimates, But Guidance Mixed  MoneyShow.com3 weeks ago 3 More Drugmakers Beat Q2 Estimates; Outlook Mixed  Investor's Business Daily3 weeks ago
Tech Times

Pfizer: Q2 2016 Progress Is Good, Headwinds Remain

Drug-maker Pfizer (NYSE: PFE ) released some pretty decent looking results for Q2 2016 . Both the Innovative Health (previously Innovative Products) and Essential Health (previously Established Products) segments generated healthy-looking revenue ...
 Seeking Alpha2 weeks ago PFIZER : Hit As Sales Of Older Drugs Fall -- WSJ  4 Traders3 weeks ago PFIZER : Results Beat Expectations Amid Strength in Innovative Health Division  4 Traders3 weeks ago Drugmakers Merck, Allergan Spark Rumors Of Biogen Takeover  Tech Times3 weeks ago

Pfizer adds to list of drugmakers under lens for deviating from good manufacturing practices

Pfizer is the latest addition to an expanding list of drug makers found deviating from good manufacturing practices in India.In the last week of June, a high profile team drawn from world's four leading regulators identified a number of deficiencies ...
 Economic Times2 weeks ago

Report: Mylan eyeing Pfizer joint venture in Brazil

A year ago, Mylan NV was fending off a hostile takeover bid by Teva Pharmaceutical Industries Ltd.. Now both drugmakers are interested in buying Pfizer's generic business in Anapolis,
 Singapore Star.com1 month ago Teva, Mylan eye Pfizer's Brazil venture, sources say  Sharenet1 month ago Teva, Mylan Eye Pfizer's Generic Venture in Brazil  Pharmaceutical Manufacturing Magazine4 weeks ago EXCLUSIVE-Teva, Mylan eye Pfizers Brazil venture, sources say  Reuters UK1 month ago

Shire buys bowel drug rights from Pfizer

Irish drugmaker Shire Plc said it would buy the rights to an experimental bowel drug from Pfizer Inc to bolster its pipeline of gastrointestinal treatments. The drug, PF-00547659, which is designed to treat moderate-to-severe inflammatory bowel disease, has ...
 Reuters2 months ago

Investors Review Drugmakers' Stocks: Pfizer, AbbVie, Merck, and J&J

With the U.S. election fast approaching, some investors cannot help but question the outcome's probable impact on the Healthcare sector. A post-election scenario may lead to potential drug-price reductions and amended policies. This morning, ...
 PharmaceuticalProcessing2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less